We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Seeking Clues to Nordson (NDSN) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Nordson (NDSN - Free Report) will report quarterly earnings of $2.61 per share in its upcoming release, pointing to a year-over-year increase of 8.3%. It is anticipated that revenues will amount to $721 million, exhibiting an increase of 9% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some Nordson metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Net Sales- Industrial Precision Solutions' at $337.46 million. The estimate indicates a year-over-year change of -8.9%.
The consensus among analysts is that 'Net Sales- Advanced Technology Solutions' will reach $164.46 million. The estimate points to a change of +32.3% from the year-ago quarter.
According to the collective judgment of analysts, 'Net Sales- Medical and Fluid Solutions' should come in at $214.82 million. The estimate indicates a year-over-year change of +28.8%.
Analysts forecast 'Operating profit (loss)- Advanced Technology Solutions' to reach $38.05 million. Compared to the present estimate, the company reported $22.95 million in the same quarter last year.
It is projected by analysts that the 'Operating profit (loss)- Medical and Fluid Solutions' will reach $60.76 million. The estimate is in contrast to the year-ago figure of $48.37 million.
The combined assessment of analysts suggests that 'Operating profit (loss)- Industrial Precision Solutions' will likely reach $112.06 million. The estimate is in contrast to the year-ago figure of $118.11 million.
Shares of Nordson have experienced a change of -0.1% in the past month compared to the +3.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), NDSN is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Seeking Clues to Nordson (NDSN) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Wall Street analysts forecast that Nordson (NDSN - Free Report) will report quarterly earnings of $2.61 per share in its upcoming release, pointing to a year-over-year increase of 8.3%. It is anticipated that revenues will amount to $721 million, exhibiting an increase of 9% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some Nordson metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Net Sales- Industrial Precision Solutions' at $337.46 million. The estimate indicates a year-over-year change of -8.9%.
The consensus among analysts is that 'Net Sales- Advanced Technology Solutions' will reach $164.46 million. The estimate points to a change of +32.3% from the year-ago quarter.
According to the collective judgment of analysts, 'Net Sales- Medical and Fluid Solutions' should come in at $214.82 million. The estimate indicates a year-over-year change of +28.8%.
Analysts forecast 'Operating profit (loss)- Advanced Technology Solutions' to reach $38.05 million. Compared to the present estimate, the company reported $22.95 million in the same quarter last year.
It is projected by analysts that the 'Operating profit (loss)- Medical and Fluid Solutions' will reach $60.76 million. The estimate is in contrast to the year-ago figure of $48.37 million.
The combined assessment of analysts suggests that 'Operating profit (loss)- Industrial Precision Solutions' will likely reach $112.06 million. The estimate is in contrast to the year-ago figure of $118.11 million.
View all Key Company Metrics for Nordson here>>>Shares of Nordson have experienced a change of -0.1% in the past month compared to the +3.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), NDSN is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .